Loss of Y Chromosome in Normal Tissue Linked to Early Cancer Development

To investigate the phenomenon known as mosaic loss of the Y chromosome (mLOY), researchers marked the centromeres of X and Y chromosomes using fluorescence in situ hybridization (FISH) probes. According to the study findings, automated image analysis evaluated a total of 4,327,315 cell nuclei. By calculating the ratio of Y signals to X signals for each sample, the team established numerical values where lower metrics indicate a higher degree of Y chromosome loss. The researchers also compared this imaging method with RNA sequencing data to measure the functional activity of Y-linked genes.

Spatial Gradients and Tissue Proximity

The analysis revealed a distinct spatial pattern regarding where chromosome loss occurs within tissue structures. Histologically unauffälliges (normal-appearing) tissue taken from cancer-free men and normal tissue collected from unaffected organs in cancer patients showed no significant differences in mLOY levels. However, normal-appearing tissue situated directly adjacent to a tumor displayed noticeably higher rates of mLOY, while the carcinomas themselves exhibited the most severe chromosome loss on average, according to the data.

Researchers examined paired samples from the same organ—consisting of both tumor tissue and adjacent normal tissue—in a cohort of 49 men. This direct comparison confirmed that Y chromosome loss was significantly elevated in the cancerous regions. Because sample sizes for individual malignancies varied, researchers grouped rarer tumor types together for statistical evaluation, though sufficient paired samples were available independently for bladder and prostate cancers.

Gene Activity and Early Cellular Changes

Complementary analysis of spatially resolved RNA data from bladder tissue reinforced the directional findings of the imaging models. Gene activity linked to the Y chromosome decreased progressively as cells transitioned from early, unusual cellular changes into invasive carcinomas. However, a paired comparison specifically evaluating these early lesions alongside invasive cancer included only five male patients, yielding a p-value of 0.059 that fell just above the standard threshold for statistical significance.

“We could show that the loss of the Y chromosome occurs in normal-appearing tissue next to a tumor,” said Dan Theodorescu, describing the significance of the finding. “Precisely this discovery makes this finding so exciting. It indicates that we may be seeing one of the earliest signposts of an emerging cancer.”

Theodorescu compared the distribution to a physical slope, noting that “we think about it now as a gradient, similar to a slope that slowly becomes steeper and steeper. The closer the tissue is to a cancer, the more Y chromosome loss we see. This gradient could one day help doctors become suspicious during biopsies that miss a smaller cancer.”

Clinical Limitations and Future Research

While the data aligns with a field effect—where molecular alterations span a wide tissue area before a distinct tumor forms—the study establishes a spatial correlation rather than proving that mLOY directly triggers the onset of cancer. Authors of the study noted several methodological constraints, including a reliance on archived tissue microarrays whose small core sizes may not fully capture heterogeneous tumors. Furthermore, samples contained a mixture of epithelial cells alongside stroma and immune cells, which could potentially skew or underestimate the measurements observed in tumor and normal tissues.

Current evidence remains insufficient to support a clinical diagnostic test based strictly on these markers. Additional single-cell and spatial analyses are required to determine which specific cell types shed their Y chromosomes first, how those altered cells migrate through tissue, and whether the observed gradient reliably predicts tumor formation sites. If validated through subsequent research, mLOY could eventually provide genetic context when standard biopsies narrowly miss suspicious lesions.